12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga·02/23/2026 17:05:36
Listen to the news
Gainers
Arcellx (NASDAQ:ACLX) shares rose 77.6% to $113.83 during Monday's regular session. The market value of their outstanding shares is at $3.7 billion.
Vanda Pharmaceuticals (NASDAQ:VNDA) stock increased by 40.41% to $8.09. The market value of their outstanding shares is at $340.4 million.
Genprex (NASDAQ:GNPX) stock moved upwards by 22.75% to $2.19. The company's market cap stands at $4.0 million.
Jyong Biotech (NASDAQ:MENS) stock increased by 22.69% to $2.47. The company's market cap stands at $152.8 million.
Enhabit (NYSE:EHAB) shares moved upwards by 22.58% to $13.6. The market value of their outstanding shares is at $561.2 million.
Fortress Biotech (NASDAQ:FBIOP) shares increased by 20.52% to $13.26. The market value of their outstanding shares is at $37.6 million.
Losers
Gossamer Bio (NASDAQ:GOSS) stock declined by 83.5% to $0.35 during Monday's regular session. The company's market cap stands at $493.0 million.
20/20 Biolabs (NASDAQ:AIDX) shares fell 28.99% to $10.49. The company's market cap stands at $152.9 million.
iSpecimen (NASDAQ:ISPC) stock declined by 17.38% to $0.23. The market value of their outstanding shares is at $2.7 million.
Novo Nordisk (NYSE:NVO) shares decreased by 15.18% to $40.23. The market value of their outstanding shares is at $210.8 billion.
Neuraxis (AMEX:NRXS) shares decreased by 14.83% to $4.71. The company's market cap stands at $58.9 million.
GRAIL (NASDAQ:GRAL) stock fell 14.03% to $43.17. The company's market cap stands at $1.9 billion. As per the news, the Q4 earnings report came out 2 days ago. See Also:www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure. Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.